 |
 |
GEO help: Mouse over screen elements for information. |
|
| Status |
Public on Aug 10, 2023 |
| Title |
Loss of Mtm1 causes cholestatic liver disease in a model of X-linked myotubular myopathy |
| Organism |
Danio rerio |
| Experiment type |
Expression profiling by high throughput sequencing
|
| Summary |
X-linked myotubular myopathy (XLMTM) is a fatal congenital disorder caused by mutations in the MTM1 gene. Currently, there are no approved treatments, though AAV8-mediated gene transfer therapy has shown promise in animal models and preliminarily in patients. However, four patients with XLMTM treated with gene therapy have died from progressive liver failure, and hepatobiliary disease has now been recognized more broadly in association with XLMTM. In an attempt to understand whether loss of MTM1 itself is associated with liver pathology, we have characterized a novel liver phenotype in a zebrafish model of this disease. Specifically, we have found that loss-of-function mutations in mtm1 lead to severe liver abnormalities including impaired bile flux, structural abnormalities of the bile canaliculus, and improper endosomal-mediated trafficking of canalicular transporters. Using a reporter tagged Mtm1 zebrafish line, we have established localization of Mtm1 in the liver in association with Rab11 and canalicular transport proteins, and demonstrated that hepatocyte specific re-expression of Mtm1 can rescue the cholestatic phenotype. Lastly, we completed a targeted chemical screen, and found that Dynasore, a dynamin II inhibitor, is able to partially restore bile flow and transporter localization to the canalicular membrane. In summary, we demonstrate for the first time liver abnormalities that are directly caused by MTM1 mutation in a pre-clinical model, thus establishing the critical framework for better understanding and comprehensive treatment of the human disease.
|
| |
|
| Overall design |
Total mRNAs were extracted from pools of dissected livers from 6 dpf abcb11b mutants and WT siblings, 20 livers per replicate and 3 replicates per genotype, by using Arcturus PicoPure RNA isolation kit (Applied Biosystems, KIT0204). Samples were submitted to Novogene Co for library preparation and RNA-sequencing using the vendor’s standard protocol. Bioinformatic analysis was performed as described above.
|
| |
|
| Contributor(s) |
Deshwar AR, Karolczak S, Dowling JJ, Yin C, Ellis J |
| Citation(s) |
37490339 |
| |
| Submission date |
Jun 22, 2023 |
| Last update date |
Nov 16, 2023 |
| Contact name |
Kristen Seim |
| E-mail(s) |
kristen.seim@gmail.com
|
| Organization name |
GraphiteBio
|
| Street address |
201 Haskins Way
|
| City |
San Francisco |
| State/province |
CA |
| ZIP/Postal code |
94080 |
| Country |
USA |
| |
|
| Platforms (1) |
|
| Samples (24)
|
|
| Relations |
| BioProject |
PRJNA986481 |
| Supplementary file |
Size |
Download |
File type/resource |
| GSE235571_Counts_zebrafish_40Livers.csv.gz |
487.6 Kb |
(ftp)(http) |
CSV |
| GSE235571_RAW.tar |
3.7 Mb |
(http)(custom) |
TAR (of SF) |
| GSE235571_abcb11b_counts.csv.gz |
183.9 Kb |
(ftp)(http) |
CSV |
SRA Run Selector |
| Raw data are available in SRA |
| Processed data are available on Series record |
|
|
|
|
 |
Less...
More...